Pharma News Archives - rfxcel.com

Antares Vision Group Launches Exception Management System for Pharmaceuticals Supply Chain 

Amid a surge in exceptions, company’s DIAMIND Sentry promotes seamless

operations and compliance with traceability regulations.

Travagliato, Italy – Antares Vision Group – a technological partner in the digitalization of products and supply chains for companies and institutions, and a leader in traceability and inspection for quality control – has launched DIAMIND Sentry, a solution allowing pharma companies to efficiently manage the substantial uptick in exceptions stemming from traceability mandates. The sophisticated system was developed by rfxcel, a business unit of Antares Vision Group providing supply chain visibility solutions.

The implementation of widespread traceability regulations, most notably the US Food & Drug Administration’s Drug Supply Chain Security Act (DSCSA), requires the electronic exchange of unit-level product data, amplifying the volume of information shared among manufacturers, wholesalers, and dispensers. However, any errors during these exchanges result in compliance exceptions, and a significant increase in these exceptions has created industry-wide challenges. Unfortunately, part of the potential for supply chain disruptions stem from inefficient partner collaboration tools. 

DIAMIND Sentry was developed to address these exception-centric obstacles by streamlining collaboration and ensuring seamless regulatory compliance. The cloud-based platform allows manufacturers, wholesalers, and dispensers to quickly identify and resolve product data exchange errors. Importantly, the system’s advanced exception management capabilities do not require platform upgrades, clearing the way for rapid deployment and immediate operational impact. 

DIAMIND Sentry automatically evaluates inbound and outbound Electronic Product Code Information Services (EPCIS) files through multiple pre-checks, including format and master data validation, ensuring they meet DSCSA standards. Files that fail any checks generate detailed validation reports. Depending on the error’s criticality, files are either blocked, flagged for review, or sent back to partners for correction. Here, automated notifications and ticketing systems facilitate quick resolution of issues, allowing partners to respond directly via email to trigger automated responses and reprocessing. 

Throughout the process, customizable dashboards provide real-time visibility into data flows, exception statuses, and purchase order tracking. Overall benefits of DIAMIND Sentry include: 

  • DSCSA compliance: DIAMIND Sentry ensures all file transactions meet DSCSA requirements for traceability and security, with automated processes for maintaining compliance, and reducing the risk of noncompliance penalties.
  • Advanced exception management: Automated file evaluations ensure data accuracy and integrity, and detailed validation reports streamline error identification and resolution.
  • Seamless collaboration: Provides automated notifications and ticketing for efficient partner communication, and allows compatible integration with existing systems like ServiceNow and Salesforce via APIs.
  • Enhanced visibility: Real-time dashboards yield operator monitoring of file success/failure rates and purchase order statuses, as well as proactive alerts for missing or erroneous files to prevent delays.
  • Reduced exception management costs: Eliminating the need for additional human resources to track, handle and report all exception cases manually.
  • User-friendly interface: The system’s responsive design is accessible on both mobile and desktop devices, with customizable views tailored to different user roles within an organization.
  • Centralized data access: The solution serves as a single access point for all exception-related data, reducing response times and improving efficiency while providing global network visibility for multi-region operations.

About Antares Vision Group 

Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency®. 

DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports business growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels and guarantees product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management, applying artificial intelligence and potentially blockchain. 

AV Group operates in the Life Science (pharmaceuticals, medical devices, and hospitals), Beverage, Food, Cosmetics, Chemicals, and Packaging industries and potentially many others. 

AV Group has been listed in STAR segment of Euronext since 14 May 2021. It has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022.

In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs over 1,300 people, and has a consolidated network of over 40 international partners.

Antares Vision Group, Through rfxcel Technology, Becomes the First DSCSA Solution Provider to Join NABP’s Pulse Interoperable Partner Program

A pharmacist in a white lab coat scanning a box of prescription medicine

AV Group, which has a long history of working with the National Association of Boards of Pharmacy, extends its commitment to DSCSA compliance by joining the Partner Program.

Travagliato (Brescia), August 29, 2023. Antares Vision Group, an Italian multinational and a leading provider of track and trace and quality control systems, today announced that it has partnered with the National Association of Boards of Pharmacy® (NABP®) through the Pulse Interoperable Partner program. This new initiative aims to accelerate interoperability in the drug supply chain by providing a framework for solution providers to integrate directly with Pulse by NABP™, an inclusive, accessible, and secure digital platform that simplifies the process of achieving Drug Supply Chain Security Act (DSCSA) compliance.

Nearly 10 years ago, the DSCSA was enacted to ensure the safety of the U.S. pharmaceutical supply chain. The law, which has a deadline of November 2023, requires cooperation and interoperability among a wide range of industry stakeholders and solution providers. As the deadline approaches, these actors must continue to work together to ensure they will meet the complex requirements of the DSCSA.

NABP has been and will continue to be a key stakeholder in the DSCSA effort, representing the needs and interests of state regulators. This includes Pulse by NABP, which facilitates DSCSA compliance across the supply chain by providing additional functionality and data required to ensure seamless interoperability among participants. Antares Vision Group, through rfxcel technology, recognizes the importance of NABP’s contributions and is proud to be the first solution provider to sign up for this partner program.

“We have been working with the NABP for years and have watched their continued commitment to the DSCSA effort,” said rfxcel Senior Vice President of Product and Strategy Herb Wong. “Their involvement offers critical insight into the needs of the state boards of pharmacy and the small dispenser community and reflects the feedback that we’ve been hearing from our customers. We are excited to participate in the Pulse Interoperable Partner Program to ensure safe pharmaceuticals for patients and consumers.”

”Antares Vision Group became the first solution provider to be a Pulse Interoperable Partner, signing on within hours of the program being announced at  NABP’s recent Interoperability Summit,” said NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh. “They have been an ardent supporter of Pulse and we’re delighted to continue the collaboration to secure the prescription drug supply chain and protect public health.”

For more information, contact Herb Wong, senior vice president of product and strategy, at hwong@rfxcel.com.

About Antares Vision Group

Antares Vision Group is driving digitalization of products and supply chains by leading traceability, inspection, and integrated data management. AV Group helps companies and institutions to achieve safety, quality, efficiency, and sustainability, enabling Trustparency®.

DIAMIND, AV Group’s integrated ecosystem of solutions, simplifies the technology environment and supports businesses’ growth by enabling a data-driven and tailored journey to digital innovation. Connecting physical products with digital identities, DIAMIND runs at the line, factory, warehouse, enterprise, and supply chain levels, and helps guarantee product quality (inspection systems and equipment) and end-to-end traceability (from raw materials to production, from distribution to the consumer and back) through integrated data management.

AV Group operates in the life science (pharmaceuticals, medical devices, and hospitals), beverage, food, cosmetics, chemicals, and packaging industries and potentially many others.

AV Group has been listed in STAR segment of Euronext since May 2021 and has been included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential, since July 2022.

In 2022, Antares Vision Group recorded a turnover of €223 million. The Group operates in 60 countries, employs more than 1,300 people, and has a consolidated network of over 40 international partners. To learn more, please visit antaresvisiongroup.com and rfxcel.com.

Spherity and Antares Vision Group further partnership to ensure life sciences customers will comply with upcoming DSCSA regulations

Antares Vision Group, through rfxcel technology, has integrated Spherity’s Credentialing Service into its DSCSA solutions to verify authorized trading partners’ identities and licensing in all regulated interactions.

Reno, Nevada, April 25, 2023 — Spherity, a German leading provider of digital wallet and credentialing solutions, and Antares Vision Group, an Italian multinational and a leading provider of track and trace and quality control systems, are continuing a partnership that helps ensure life sciences customers comply with this year’s U.S. Drug Supply Chain Security Act (DSCSA) regulations.

By November 27, 2023, manufacturers, distributors, dispensers, and other actors in the life sciences supply chain must prove that they are legitimate organizations, or authorized trading partners (ATPs), as defined by the DSCSA.

The two companies first partnered in 2021, when Spherity’s Credentialing Solution, CARO, was integrated into the Group’s Verification Router Service (VRS) solution, enabled by rfxcel technologies, to allow life science customers to confirm their ATPs status. The combined solution also allows customers to exchange DSCSA-compliant electronic Product Identifier (PI) messages, trace products, and create an audit trail of their VRS business interactions.

CARO uses Self-Sovereign Identity (SSI) technology to establish a secure, verifiable digital enterprise identity for every ATP. By integrating the service into its VRS solution, rfxcel customers can ensure secure, authenticated data exchange with other ATPs and verify they have the credentials required by the DSCSA, including state licenses and U.S. Food and Drug Administration Entity Identifiers (FEIs).

“We partnered with Spherity to enable our customers to comply with this year’s DSCSA authorized trading partner (ATP) requirements,” said rfxcel Senior Vice President of Product and Strategy Herb Wong. “With Spherity’s CARO, our VRS solution automatically confirms whether a company is an ATP. Now, every customer can add ATP credentialing to our entire product portfolio and secure their VRS interactions.”

“Spherity will ensure that Antares Vision Group’s customers can securely exchange data with previously unknown entities,” said Georg Jürgens, Spherity’s Manager for Industry Solutions. “The concept of exchanging and verifying credentials using Digital Wallets supports company and product compliance use cases that require communication between regulators, existing supply chain partners, and new trading partners.”

Spherity and Antares Vision Group are members of the Open Credentialing Initiative (OCI), and both contribute to the standardization and industry-wide interoperability of credentialing technology.

For more information about the Spherity-Antares Vision Group partnership, their solutions for DSCSA compliance with ATP requirements, and the Open Credentialing Initiative, contact Spherity’s Manager for Industry Solutions Georg Jürgens at georg.juergens@spherity.com and visit caro.vc, and rfxcel Senior Vice President of Product and Strategy Herb Wong at hwong@rfxcel.com.

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of Euronext; furthermore, from July 2022 included in the Euronext Tech Leaders index, dedicated to leading tech companies with high growth potential. In 2022, Antares Vision Group recorded a turnover of €223.5 million. The Group operates in 60 countries, employs more than 1,100 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvision.com and www.antaresvisiongroup.com.

ABOUT SPHERITY

Spherity is a German software provider bringing secure and decentralized identity management solutions to enterprises, machines, products, data and even algorithms. Spherity provides the enabling technology to digitalize and automate compliance processes in highly regulated technical sectors. Spherity’s products empower cybersecurity, efficiency and data interoperability among digital value chains. Spherity is certified according to the information security standard ISO 27001.

Antares Vision Group, Through rfxcel, Begins Partnership with Renown Health Network for DSCSA-Compliant Pharmaceutical Tracking

rfxcel, part of Antares Vision Group, will implement DSCSA compliance solutions to help ensure pharmacies across the northern Nevada healthcare network comply with the regulations.

Reno, Nevada, March 8, 2023 — Antares Vision Group (EXM, AV:IM), a leading provider of track and trace and quality control systems, today announced that rfxcel, which is part of the Group, has begun a partnership with Renown Health Foundation to implement compliance software so the network can track and trace pharmaceuticals in compliance with the Drug Supply Chain Security Act (DSCSA).

With rfxcel’s DSCSA compliance solutions, Renown Health’s medical groups and pharmacies will achieve real-time electronic tracing of drug products at the package level to identify and trace prescription drugs as they are distributed throughout the health system. This will enhance Renown’s ability to help protect patients from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful.

“Reno has been our home since 2018 and many of our employees live and work in the northern Nevada region,” said rfxcel CEO Glenn Abood. “Renown is one of the leading not-for-profit healthcare organizations here and is the perfect partner to team with to give back to our community. We are excited about the opportunity to work with them and to help improve the health and well-being of our friends and neighbors.”

“Ensuring our patient’s medications are safe and legitimate is of the upmost importance to us,” said Renown’s Vice President of Pharmacy Services Adam Porath. “When members of our community get involved in our work, it brings us all closer together. We are thankful that Antares Vision Group and rfxcel are partnering with us on our healing mission. They are making it possible for us to keep our patients safe, comply with the demanding DSCSA requirements, and respond quickly to changing supply chain requirements.”

For further information, write us at news@rfxcel.com.

 

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for companies and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. The Group provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer) through integrated data management, applying artificial intelligence and blockchain technology. Antares Vision Group is active in life science (pharmaceutical, biomedical devices and hospitals) and Fast-Moving Consumer Goods (FMCG), including food, beverage, cosmetics, and glass and metal containers. As a world leader in track and trace solutions for pharmaceutical products, the Group provides major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions, monitoring their supply chains and validating product authenticity. Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from 14 May 2021 in the STAR segment of the Mercato Telematico Azionario (MTA), Antares Vision Group recorded a turnover of €179 million in 2021, operates in 60 countries, employs more than 1,000 people, and has a consolidated network of over 40 international partners. To learn more, please visit www.antaresvision.com and www.antaresvisiongroup.com.

ABOUT RENOWN HEALTH

Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 9,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®.

Antares Vision Group Acquires ACSIS

AVG Chairman & Co-CEO Emidio Zorzella says the acquisition will allow Antares Vision Group to enter the multi-billion-dollar returnable asset management market.

Reno, Nevada, Feb. 15, 2022 (EINPRESSWIRE).  Antares Vision Group (AVG), a leading global provider of hardware and software track and trace solutions and one of the major players in inspection systems and smart data management, today announced that it had acquired ACSIS Inc. through its fully controlled company rfxcel for an enterprise value of $12 million.

Founded in 1996, ACSIS has been providing solutions and services to Fortune 1000 manufacturing companies with some of the most complex and highly regulated supply chains in the world for more than 20 years. It delivers innovative software solutions and services to companies with complex warehouse, distribution, and packaging challenges, assists with their data collection requirements for track and trace and inventory optimization through their supply chains, and delivers seamless integration of information to their ERP systems. ACSIS has had zero churn among its Top 10 customers, which include DuPont, Cintas, BIMBO, Hershey and Coca-Cola. AVG will retain ACSIS’ highly experienced and proven executive team.

“The ACSIS acquisition will further strengthen our unique end-to-end solution for the digital supply chain,” rfxcel CEO Glenn Abood said. “It will provide new customers and allow us to enter into new industry verticals, as well as into the relevant returnable asset management market, extending our presence in the United States.”

ACSIS CEO Jeremy Coote said the acquisition brought together industry-leading organizations and technologies. “For more than 20 years, our incredibly talented team has been at the forefront of creating some of the most sophisticated supply chain visibility solutions for manufacturing companies around the world,” he said. “The combination of Antares Vision Group’s world-class talent with ACSIS technology, domain expertise, and commitment to innovating supply chain ecosystems will help ensure our success in an increasingly competitive industry.”

With its deep domain expertise in data collection and serialization, ACSIS in 2019 launched the ACSIS Cloud Platform, a next-generation cloud-based supply chain visibility platform that spans data collection to business process to real-time analytics and uniquely enables personalized, private supply chain edge ecosystems. The ACSIS Cloud Platform solves the toughest supply chain visibility challenges, including:

Product traceability: item-level tracking using serialization, barcodes, RFID, and other sensors; edge data collection; visibility across multi-partner ecosystems to ensure regulatory compliance, improve public safety, and enable sustainable supply chains

Returnable asset management: tracks returnable transport items (RTIs) across the extended supply chain in real time to deliver accurate inventory status; ensures compliance and efficiency; controls shrinkage and ensures proper maintenance and inspection of RTIs; predicts demand to support improved planning and customer service

Partner collaboration: integrates with partners across operating ecosystems; delivers real-time supply chain and production visibility; creates more transparent and agile supply chains; maintains common enterprise standards; ensures consistent serialization data and uniform product labeling

About Antares Vision Group

Antares Vision Group is an outstanding technology partner in digitalization and innovation for enterprises and institutions, guaranteeing the safety of products and people, business competitiveness, and environmental protection. Antares Vision Group is a technological enabler of supply chain transparency and sustainable transition to protect business competitiveness and the uniqueness of each country. It provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials and production to distribution to the consumer), with integrated data, production and supply chain management, also achieved through the application of artificial intelligence and the use of blockchains.

Antares Vision Group is active in the life sciences sector (pharmaceutical, biomedical devices, and hospitals), in the beverage, food, and cosmetics industries, and has potential in other sectors. The world leader in track and trace systems for pharmaceutical products, it provides major global manufacturers (more than 50 percent of the Top 20 multinationals) and numerous government authorities with solutions to monitor their supply chains and validate product authenticity.

Listed since April 2019 on the Italian Stock Exchange in the Alternative Investment Market (AIM) segment and from May 14, 2021, in the STAR segment of the Mercato Telematico Azionario (MTA) (electronic equity market), Antares Vision Group recorded a turnover of Euro 162 million in 2020, operates in 60 countries, employs approximately 1,000 people, and has a consolidated network of more than 40 international partners. For more information, visit antaresvision.com and antaresvisiongroup.com.

About rfxcel

Part of Antares Vision Group, rfxcel has a long history of providing leading-edge software solutions to help companies build and manage their digital supply chain, lower costs, protect their products and brand reputations, and engage consumers. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s Traceability System to power end-to-end supply chain solutions in track and trace, environmental monitoring, regulatory compliance, serialization, and visibility. Founded in 2003, the company is headquartered in the United States.

Mobilogix and rfxcel Announce Strategic Partnership in IoT Solutions

Irvine, Calif., Oct. 13, 2021 (PRNewswire). Mobilogix, the leading provider of cost-optimized state-of-the-art cellular IoT solutions, today announced a strategic partnership with rfxcel, part of Antares Vision Group and a leading serialization and traceability enterprise solution provider. Together, the companies will offer innovative supply chain and logistics IoT solutions that complement each other’s strengths to greater serve growing market demands, including asset tracking and traceability for full end-to-end supply chain visibility.

Mobilogix will support rfxcel with an array of its solutions, including the BAT-X IoT tracker and BTM250 Bluetooth beacon sensor. rfxcel’s track and trace software solutions meet the growing demand for smart, scalable asset-tracking optimized for logistics and supply chain use cases. “It is a critical time to serve the market’s growing needs,” said Charlie Williams, EVP Sales and Marketing at Mobilogix. “We are pleased to leverage our synergies to penetrate the market for both partners.”

“We are excited about partnering with Mobilogix to provide track and trace solutions that utilize the latest and best IoT technologies,” said rfxcel CEO Glenn Abood. “By combining Mobilogix’s innovative hardware with our best-in-class track and trace software, we offer better data and operational outcomes for any market and any industry.”

For more information about rfxcel and the Mobilogix partnership, contact rfxcel Vice President of Marketing and Strategic Initiatives Herb Wong at 925-791-3235 or hwong@rfxcel.com.

About Mobilogix

Mobilogix is the world’s leading provider in IoT asset optimization and management solutions. The company’s solutions are deployed by leading companies in Agriculture, Automotive, Construction, Industrial and Transportation to track, monitor, and optimize their assets with actionable real-time data. Mobilogix is headquartered in Irvine, California, and has global offices in BrazilIndiaHong Kong and China. For more information, please call +1.949.748.8895, e-mail info@mobilogix.com.

About rfxcel

Part of Antares Vision Group, rfxcel provides leading-edge software solutions to help companies build and manage their digital supply chain, lower costs, protect their products and brand reputations, and engage consumers. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s Traceability System to power end-to-end supply chain solutions in track and trace, environmental monitoring, regulatory compliance, serialization, and visibility. Founded in 2003, the company is headquartered in the United States and has offices in the United Kingdom, the EU, Latin AmericaRussiaIndiaJapan, the Middle East, and the Asia-Pacific region.

About Antares Vision Group

Antares Vision Group protects products, people, and brands with inspection systems featuring 6,500 quality controls, track and trace software solutions for end-to-end transparency and visibility in digital supply chains, and smart data management tools for maximum operational efficiency, from raw materials to final consumers. It provides solutions to five primary industries: pharmaceuticals and life sciences (medical devices and hospitals), food and beverage, cosmetics, and consumer packaged goods. Active in more than 60 countries, Antares Vision Group has seven production facilities and three Innovation and Research Centers in Italy, 22 foreign subsidiaries, and a global network of more than 40 partners. Today, 10 of the world’s 20 leading pharmaceutical companies use its solutions to secure their production and supply chain operations; worldwide, it has deployed more than 25,000 inspection systems and more than 3,500 serialization modules. Antares Vision Group has been listed on the Italian Stock Exchange’s AIM Italia market since April 2019 and in the STAR Segment of the Mercato Telematico Azionario (MTA) since May 2021.

rfxcel, Part of Antares Vision Group, and MVC Launch the Traceability Hub for the Kingdom of Bahrain to Track End-to-End Pharma Supply Chain

Travagliato (Brescia), June 3, 2021 (MarketScreener). Antares Vision Group, the international leader in the pharmaceutical sector for track and trace hardware and software solutions (anti-counterfeiting and supply chain transparency), with an established presence in inspection systems (quality control), and active in smart data management (production efficiency and end-to-end supply chain digitalization, from raw materials to the final consumer), announced today that its subsidiary rfxcel has successfully implemented an end-to-end Traceability Hub to monitor and secure the Kingdom of Bahrain’s global pharmaceutical supply chain process. The initial value of this contract is approximately 4-6 percent of Antares Vision FY 2020 pro-forma revenues.

Bahrain’s National Health Regulatory Authority (NHRA) and Supreme Council of Health selected Medical Value Chain (MVC) and its partner rfxcel to provide the first GS1-compliant system to track its entire pharmaceutical supply chain on a blockchain platform. The end-to-end Traceability Hub delivers complete visibility into every node of the Kingdom’s supply chain, from the manufacturer of origin, importers, wholesalers, and distributors to pharmacies, clinics, and hospitals — all the way to individual patients.

The objective of the NHRA Bahrain Traceability Hub is to achieve following:

  • End-to-end traceability for all medicine imports to Bahrain
  • Bahrain pharma supply chain to meet the global track and trace requirements and GS1 standards
  • Complete visibility and repository of medicine inventory and supply-chain info from manufacturers to agents/importers to wholesalers/distributors to pharmacies/hospitals and to patients/consumers
  • Increase patient safety
  • Detect and stop counterfeit medicines
  • Analytics of medicine imports and consumption in Bahrain
  • Manage product recalls and shortages efficiently and quickly

Glenn Abood, rfxcel CEO, said, “The end-to-end Traceability Hub offers an array of other benefits for all pharmaceutical supply chain stakeholders. The Hub is the first of its kind in the Gulf Cooperation Council. It creates a single source of truth for all medications, which means improved patient safety, better flow of information, and more accurate inventory management. It is also a powerful tool to prevent counterfeit and substandard drugs from reaching the market.”

Emidio Zorzella, Antares Vision Group CEO, said, “I am honored that the Kingdom of Bahrain chose Antares Vision Group in partnership with MVC to secure and optimize its pharma supply chain. In the near future, we expect to announce national traceability hubs in other countries to track pharmaceutical, agricultural, and consumer products.”

MVC President Leo Giacometto said, “When we set up our company to provide a blockchain-enabled track and trace platform to provide customs clearances and supply chain financing, we needed the absolute best track and trace solution and most experienced team in the market; that is rfxcel, now part of Antares Vision Group!”

ABOUT RFXCEL

Part of Antares Vision Group, rfxcel provides leading-edge software solutions to help companies build and manage their digital supply chain, lower costs, and protect their products and brand reputations. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s signature Traceability System (rTS) to power end-to-end supply chain solutions in key areas such as track and trace, environmental monitoring, regulatory compliance, serialization, and visibility. Founded in 2003, the company is headquartered in the United States and has offices in the United Kingdom, the EU, Latin America, Russia, India, Japan, the Middle East, and the Asia-Pacific region.

ABOUT ANTARES VISION GROUP

Listed since April 2019 on the Italian Stock Exchange in the AIM Market, and from 14 May 2021 on Mercato Telematico Azionario (MTA) STAR segment, the Antares Vision Group guarantees protection of products, people and brands through inspection systems for quality control, Track & Trace solutions for anti-counterfeiting and supply chain transparency, smart data management tools for maximized efficiency and digitalization of the supply chain, from raw materials to the final consumer. The Antares Vision Group is active in the pharmaceutical market and in Life Science in general (biomedical devices and hospitals), in beverage, food, cosmetic and in consumer-packaged goods. The Group reaches over 60 countries in the World with complete and flexible solutions, hardware, and software, with related services and counts 7 production facilities in Italy (Brescia, Parma, Piacenza, Latina, Padua and Vicenza), 22 foreign subsidiaries (Germany [2], France [2], USA [5], Brazil [2], United Kingdom [2], India, Russia [3], Hong Kong, China, Ireland, Croatia and Serbia), 3 Innovation and Research Centers (Italy) and a worldwide network of more than 40 partners. Thanks to the twenty years of experience in vision technologies of the two founding partners, the Antares Vision Group is the supplier of 10 out of 20 leading pharmaceutical companies in the world, with more than 25.000 inspection systems, that ensure everyday product safety and quality, 6.500 quality controls and more than 3.500 serialization modules on lines installed all over the. With the aim of continuing and supporting the growth and development strategy, during 2019 participation agreements were finalized with T2 Software, a Brazilian company specialized in smart data management solutions, and Orobix, an Italian company leader in artificial intelligence services, as well as the acquisition of 100% of FT System, leader in control and inspection in the beverage sector. In 2020, Antares Vision acquired 82.83% of Tradeticity, a Croatian company specialized in software management of traceability and serialization processes, 100% of Convel, an Italian company specialized in automated inspection machines for the pharmaceutical industry, the assets of Adents High Tech International, a French company specialized in software for serialization and traceability, 100% of Applied Vision, a global leader in inspection systems for glass and metal containers in food beverage. In March 2021, Antares Vision acquired 100% of rfxcel Corporation, specialized in software solutions for digitalization and supply chain transparency based in the U.S., and 100% of Pen-Tec and Tecnel, through FT System, increasing specialization in Food & Beverage inspection sector. In 2019 Emidio Zorzella and Massimo Bonardi won the Ernst & Young “Entrepreneur of the Year” award for innovation.

For further information:

ANTARES VISION S.P.A.

Via Del Ferro, N. 16

25039 – Travagliato (BS)

Alessandro Baj Badino, Investor Relator

Tel.: +39 030 72 83 500

E-mail: Investors@antaresvision.com

RFXCEL

Herb Wong, Vice President of Marketing and Strategic Initiatives

Tel.: +1 925-791-3235

E-mail: hwong@rfxcel.com

IR ADVISOR

IR Top Consulting

Via Bigli, N. 19

20121 – Milano

Tel.: +39 02 45473884

Maria Antonietta Pireddu: m.pireddu@irtop.com

Antonio Buozzi: a.buozzi@irtop.com

 

 

rfxcel to Integrate Spherity Credentialing Service into Its VRS Solution for DSCSA Authorized Trading Partner Compliance

Beginning in June, rfxcel customers can use the service to confirm their authorized trading partner status in saleable return verifications.

Reno, Nevada, June 3, 2021 (EINPRSSWIRE). rfxcel, part of Antares Vision Group and a global leader in digital supply chain traceability solutions, today announced it would integrate the Spherity Credentialing Service into its Verification Router Service (VRS) solution, enabling companies to verify their authorized trading partner (ATP) status per requirements in the U.S. Drug Supply Chain Security Act (DSCSA).

rfxcel customers can begin using the service in June. As mandated by the DSCSA, only ATPs will be permitted to exchange information in the U.S. pharmaceutical supply chain starting on November 27, 2023.

The Spherity Credentialing Service uses blockchain technology to establish a secure, verifiable digital enterprise identity for every ATP. By integrating the service into its VRS solution, rfxcel customers can ensure secure, authenticated data exchange with other ATPs and verify they have the credentials required by the DSCSA, including state licenses and U.S. Food and Drug Administration Entity Identifiers (FEIs).

Herb Wong, vice president of marketing and strategic initiatives at rfxcel, said the partnership builds on the relationship built with Spherity in the Open Credentialing Initiative (OCI), a user group comprising industry stakeholders working on rolling out, standardizing, and exploring credential-based implementations in the pharmaceutical supply chain.

“rfxcel is excited to partner with Spherity to ensure the integrity of both the physical and digital supply chain,” he said. “The Spherity Credentialing Service is the most comprehensive effort to address the upcoming ATP requirement for DSCSA and is a good match with our industry-leading VRS solution. Spherity’s leadership in the OCI was impressive, and rfxcel looks forward to offering our customers these complementary solutions this summer.”

Spherity CEO Dr. Carsten Stöcker said, “rfxcel, as an innovation pioneer in the industry, and Spherity have been a good fit from the very beginning, since the start of the collaboration. We are now very proud that rfxcel is offering our new Spherity Credentialing Service to their customers and look forward to delivering further integrations to establish trust in supply chains.”

For more information about the rfxcel-Spherity partnership, rfxcel’s solutions for DSCSA compliance, including the VRS, and the OCI, contact Vice President of Marketing and Strategic Initiatives Herb Wong at hwong@rfxcel.com and visit rfxcel.com, or Antares Vision PR Specialist Davide Antonioli at davide.antonioli@antaresvision.com and visit AntaresVision.com.

ABOUT RFXCEL

Part of Antares Vision Group, rfxcel provides leading-edge software solutions to help companies build and manage their digital supply chain, lower costs, and protect their products and brand reputations. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s signature Traceability System (rTS) to power end-to-end supply chain solutions in key areas such as track and trace, environmental monitoring, regulatory compliance, serialization, and visibility. Founded in 2003, the company is headquartered in the United States and has offices in the United Kingdom, the EU, Latin America, Russia, India, Japan, the Middle East, and the Asia-Pacific region.

ABOUT SPHERITY

Spherity is building decentralized digital identity management solutions to power the fourth industrial revolution, bringing secure identities to enterprises, machines, products, data and even algorithms. We provide the enabling technology to digitize and automate compliance processes primarily on highly-regulated technical sectors like pharmaceuticals, automotive and logistics. Spherity’s decentralized cloud identity wallet empowers cyber security, efficiency and data interoperability among digital value chains. Spherity is certified according to the information security standard ISO 27001.

ABOUT ANTARES VISION GROUP

Listed since April 2019 on the Italian Stock Exchange in the AIM Market, the Antares Vision Group guarantees protection of products, people and brands through inspection systems for quality control, Track & Trace solutions for anti-counterfeiting and supply chain transparency, smart data management tools for maximized efficiency and digitalization of the supply chain, from raw materials to the final consumer. The Antares Vision Group is active in the pharmaceutical market and in Life Science in general (biomedical devices and hospitals), in beverage, food, cosmetic and in consumer-packaged goods. The Group reaches over 60 countries in the World with complete and flexible solutions, hardware, and software, with related services and counts 7 Italian sites (Brescia, Parma, Piacenza, Latina, Collecchio, Mestrino e Vicenza), 22 company sites worldwide (Germany, France [3], USA [7], Latin America [2], UK, Spain, South Korea, India, Russia, Hong Kong, China, Croatia and Serbia), 3 Innovation and Research Centers (Italy) and a worldwide network of more than 40 partners. Thanks to the twenty years of experience in vision technologies of the two founding partners, the Antares Vision Group is the supplier of 10 out of 20 leading pharmaceutical companies in the world, with more than 25.000 inspection systems, that ensure everyday product safety and quality, 6.500 quality controls and more than 3.500 serialization modules on lines installed all over the. With the aim of continuing and supporting the growth and development strategy, during 2019 participation agreements were finalized with T2 Software, a Brazilian company specialized in smart data management solutions, and Orobix, an Italian company leader in artificial intelligence services, as well as the acquisition of 100% of FT System, leader in control and inspection in the beverage sector. In 2020, Antares Vision acquired 82.83% of Tradeticity, a Croatian company specialized in software management of traceability and serialization processes, 100% of Convel, an Italian company specialized in automated inspection machines for the pharmaceutical industry, the assets of Adents High Tech International, a French company specialized in software for serialization and traceability, 100% of Applied Vision, a global leader in inspection systems for glass and metal containers in food & beverage. In March 2021, Antares Vision acquired 100% of rfxcel Corporation, specialized in software solutions for digitalization and supply chain transparency based in the U.S., and 100% of Pen-Tec and Tecnel, through FT System, increasing specialization in Food & Beverage inspection sector. In 2019 Emidio Zorzella and Massimo Bonardi won the Ernst & Young “Entrepreneur of the Year” award for innovation.

FOR FURTHER INFORMATION

Antares Vision PR Specialist

Davide Antonioli, davide.antonioli@antaresvision.com | M. +39 339 8124446

rfxcel Vice President of Marketing and Strategic Initiatives

Herb Wong, hwong@rfxcel.com | 925-791-3235

rfxcel Adopts Open Credentialing Initiative (OCI) to meet DSCSA Authorized Trading Partner (ATP) requirements

Reno, Nevada, March 24, 2021 (EINPRESSWIRE). rfxcel, a global leader in digital supply chain traceability solutions, today announced that it would use the Open Credentialing Initiative (OCI) to help customers comply with the upcoming authorized trading partner (ATP) requirements of the U.S. Drug Supply Chain Security Act (DSCSA).

By November 27, 2023, only ATPs will be permitted to exchange information in the U.S. pharmaceutical supply chain. To test the OCI solution’s effectiveness in meeting this requirement, rfxcel joined the OCI ATP pilot, initiated and supported by key industry participants, including manufacturers, a wholesaler, and a dispenser.

In the pilot, rfxcel partnered with SAP to test the OCI solution, which was built using Spherity’s identity wallet and Legisym’s identity/license verification service. It is based on open, published standards that can be implemented by providers and avoid “vendor-lock” to ensure independence and interoperability.

“Although rfxcel continues to evaluate other ATP solutions, this is the most mature and comprehensive in the industry,” said rfxcel Vice President of Marketing and Strategic Initiatives Herb Wong. “rfxcel has been championing DSCSA initiatives for years, and we actively partner with others to ensure DSCSA readiness by 2023. We were impressed to see how seamlessly the OCI solution integrated with our own. Once we received the specs, it took us only one week to implement the solution and begin testing. The support we received from Spherity and Legisym was outstanding. By any measure, the pilot was a success, and rfxcel is excited to offer OCI to our customers.”

Georg Jürgens, Spherity’s manager of industry solutions, said digitalizing ATP verification enables use cases that go beyond DSCSA regulations. “That’s just the tip of the iceberg,” he said. “We envision that trading partners won’t have to manually verify their new business partners’ process and can leverage ATP credentials in other ways, such as order to cash or drop shipment processes. Plus, the provided enterprise identity wallets and credentials will change the way trading partners digitally interact with each other. Decentralized identifiers and verifiable credentials solutions have the potential to be used and adopted as well in other supply chain use cases.”

“When approached by the Healthcare Distribution Alliance, Legisym was thrilled to take part in the DSCSA ATP pilot and work alongside industry participants and industry service providers,” said Legisym President David Kessler. “Through collaboration, forward thinking, and innovation brought to the table by all involved, the pilot team designed a successful solution to answer all requirements and guidelines. As a regulatory compliance technology solution provider, Legisym’s focus and experience in both the highly regulated Controlled Substance Ordering System space and the complex nuisances and inconsistencies trading partners are met with when attempting to verify state-level licensing among different Boards of Pharmacy lead to a natural fit for us to engage in the role of a credential issuer.”

For more information about the OCI and rfxcel’s solutions for DSCSA compliance, contact Vice President of Marketing and Strategic Initiatives Herb Wong at hwong@rfxcel.com and visit rfxcel.com.

About rfxcel

Founded in 2003, rfxcel provides leading-edge software solutions to help companies build and manage their digital supply chain, lower costs, and protect their products and brand reputations. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s signature Traceability System (rTS) to power end-to-end supply chain solutions in key areas such as track and trace, environmental monitoring, regulatory compliance, serialization, and visibility. The company is headquartered in the United States and has offices in the United Kingdom, the EU, Latin America, Russia, India, Japan, the Middle East, and the Asia-Pacific region.

About Spherity

Spherity is building decentralized digital identity management solutions to power the fourth industrial revolution, bringing secure identities to enterprises, machines, products, data and even algorithms. We provide the enabling technology to digitize and automate compliance processes primarily on highly-regulated technical sectors like pharmaceuticals, automotive and logistics. Spherity’s decentralized cloud identity wallet empowers cyber security, efficiency and data interoperability among digital value chains. Spherity is certified according to the information security standard ISO 27001.

About Legisym, LLC

For over a decade, Legisym, LLC has successfully provided the pharmaceutical industry with affordable and effective regulatory compliance technologies. In early 2020, driven by the 2023 authorized trading partner (ATP) requirements, Legisym began leveraging their existing Controlled Substance Ordering System (CSOS) and license verification technologies and experience, to engage as a credential issuer. By performing thorough credential issuer due diligence processes, first to establish a root of trust, Legisym promotes confidence in the trading partner’s digital identity prior to the issuance of all ATP credentials.

rfxcel Enters into Acquisition Agreement with Antares Vision Group

The combination of rfxcel’s industry-leading traceability software platform and Antares Vision’s solutions for intelligent track and trace will create significant value for customers.

Reno, Nevada, Feb. 19, 2021 (EINPRESSWIRE). rfxcel, a global leader in digital supply chain traceability solutions, today announced that it had entered into an acquisition agreement with Italy’s Antares Vision Group, a leading global provider of intelligent track and trace, inspection, and smart data management solutions for the life sciences and food and beverage sectors.

rfxcel CEO Glenn Abood said the agreement marked the start of an expansive era for the company he co-founded with Chief Strategy Officer Jack Tarkoff in 2003. “This is an exciting new chapter for rfxcel,” he said, “a time for the company and our customers to look to the future.

“Becoming part of Antares Vision Group will give us new ways to strengthen our relationships with our customers and provide them with enhanced solutions as they do their important work in the life sciences, food and beverage, consumer goods, and government industries. Plus,” Abood continued, “the integration of our companies’ capabilities will enable us to drive into new markets and geographies as the undisputed leader in supply chain track and trace solutions. It really is a ‘win-win’ for our global teams and our customers.”

The Antares Vision Group will leverage rfxcel’s capabilities and signature rfxcel Traceability System (rTS) software suite to help customers accelerate their transition toward digital and sustainable supply chains characterized by full transparency and visibility. Together, the companies will provide a full stack, end-to-end digital supply chain solution that will optimize and streamline customers’ operations while providing complete end-to-end visibility, from product ingredients and raw materials to the end customer experience.

rTS is a digital supply chain visibility platform comprising up to eight discrete solutions that work in concert to harmonize, optimize, automate, and monitor virtually every aspect of supply chain operations, including serialization, regulatory compliance, Internet of Things (IoT)-enabled monitoring, and raw materials and finished goods traceability. rfxcel also offers a Mobile Traceability app that extends the power of rTS to users at every node of the supply chain, from remote fields and warehouses to retail outlets.

Emidio Zorzella, chairman and CEO of Antares Vision, said he and co-founder Massimo Bonardi were “delighted” about the agreement with rfxcel. “Demand for traceability and serialized products and services has increased significantly over the last few years,” he said, “and this transaction accelerates our ability to offer best-in-class propositions in all our key reference sectors, life science and food and beverage. We look forward to welcoming the management and employees of rfxcel to the Antares Vision Group and working together to serve our customers across the world.”

Abood added that both companies shared the same goals and Antares Vision would help rfxcel accelerate its plans. “The rfxcel management team is delighted to join with Antares Vision to offer customers the most complete end-to-end solution for track and trace on the market today.”

For more information about the acquisition agreement or the companies’ solutions, contact Herb Wong, rfxcel’s vice president of marketing and strategic initiatives, at hwong@rfxcel.com or 925-824-0300.

About rfxcel

Founded in 2003, rfxcel provides leading-edge software solutions to help companies build and manage their digital supply chain, lower costs, and protect their products and brand reputations. Blue-chip organizations in the life sciences (pharmaceuticals and medical devices), food and beverage, worldwide government, and consumer goods industries trust rfxcel’s signature Traceability System (rTS) to power end-to-end supply chain solutions in key areas such as track and trace, environmental monitoring, regulatory compliance, serialization, and visibility. The company is headquartered in the United States and has offices in the United Kingdom, the EU, Latin America, Russia, India, Japan, the Middle East, and the Asia-Pacific region.

About Antares Vision

Listed since April 2019 on the AIM Italia market of the Italian Stock Exchange, Antares Vision Group guarantees the protection of products, people and brands through inspection systems for quality control, track and trace solutions for anti-counterfeiting and supply chain transparency, smart data management tools for maximized efficiency and digitalization of the supply chain, from the point of production to the end consumer. The Antares Vision Group is active in the life science sector, including the pharmaceutical, medical device, and hospital segments, as well as in other industries, including, primarily, food and beverage, cosmetics, and in consumer-packaged goods. The Group reaches over 60 countries worldwide with complete and flexible solutions, hardware, and software, with related services: it has five offices in Italy (Brescia, Parma, Piacenza, Latina and Vicenza), 15 foreign branches (Germany [2], France [2], USA [3], Latin America [2], India, Russia, Hong Kong, China, Croatia, and Serbia), three Innovation and Research Centers (Italy) and a worldwide network of more than 40 partners. With the 20 years of experience in vision technologies of the two founding partners, the Antares Vision Group is the supplier of 10 of the 20 leading pharmaceutical companies in the world (by turnover), with more than 25,000 inspection systems, which ensure everyday product safety and quality, 6,500 quality controls, and more than 3,500 serialization modules on lines installed all over the world. With the aim of continuing and supporting the growth and development strategy, during 2019, Antares Vision finalized participation agreements with T2 Software, a Brazilian company specialized in smart data management solutions, and Orobix, an Italian company leader in artificial intelligence services, and acquired 100 percent of FT System, leader in control and inspection in the beverage sector. In 2020, Antares Vision acquired 82.83 percent of Tradeticity, a Croatian company specialized in software management of traceability and serialization processes, 100 percent of Convel, an Italian company specialized in automated inspection machines for the pharmaceutical industry, the assets of Adents High Tech International, a French company specialized in software for serialization and traceability, and 100 percent of Applied Vision, a global leader in inspection systems for glass and metal containers in food and beverage. In 2019, Emidio Zorzella and Massimo Bonardi won the Ernst & Young “Entrepreneur of the Year” award for innovation. For more info: www.antaresvision.com.